Article Correctness Is Author's Responsibility: Commonly used anti-rejection drug could be repurposed to treat some liver cancers

Research in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers.